NDC 0310-3040 – Saphnelo
Anifrolumab 300 mg/2mL · Injection, Solution · Intravenous
Product NDC0310-3040
Product details
- Brand name
- Saphnelo
- Generic name
- Anifrolumab-fnia
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761123
- Marketed since
- July 30, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Type I Interferon Receptor Antagonist
Active ingredients
- Anifrolumab 300 mg/2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0310-3040-00 | 1 VIAL, GLASS in 1 CARTON (0310-3040-00) / 2 mL in 1 VIAL, GLASS | Jul 30, 2021 |
Other Saphnelo products
- 0310-3080 Anifrolumab 120 mg/.8mL · Injection, Solution · AstraZeneca Pharmaceuticals LP